offline
Eli Lilly (LLY) Surpasses Q1 Earnings and Revenue Estimates
Eli Lilly (LLY) came out with quarterly earnings of $1.75 per share, beating the Zacks Consensus Estimate of $1.55 per share. This compares to earnings of $1.33 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 12.90%. A quarter ago, it was expected that this drugmaker would post earnings of $1.52 per share when it actually produced earnings of $1.73, delivering a surprise of 13.82%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Lilly, which belongs to the Zacks Large Cap Pharmaceuticals industry, posted revenues of $5.86 billion for the quarter ended March 2020, surpassing the Zacks Consensus Estimate by 6.32%. This compares to year-ago revenues of $5.09 billion.
...
https://finance.yahoo.com/news/eli-lilly...11792.html
![[Bild: LLYc1dl0702.png]](https://finviz.com/publish/042720/LLYc1dl0702.png)
Eli Lilly (LLY) came out with quarterly earnings of $1.75 per share, beating the Zacks Consensus Estimate of $1.55 per share. This compares to earnings of $1.33 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 12.90%. A quarter ago, it was expected that this drugmaker would post earnings of $1.52 per share when it actually produced earnings of $1.73, delivering a surprise of 13.82%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Lilly, which belongs to the Zacks Large Cap Pharmaceuticals industry, posted revenues of $5.86 billion for the quarter ended March 2020, surpassing the Zacks Consensus Estimate by 6.32%. This compares to year-ago revenues of $5.09 billion.
...
https://finance.yahoo.com/news/eli-lilly...11792.html
__________________
